Telemedicine for Outpatient Neurosurgical Oncology Care: Lessons Learned for the Future During the COVID-19 Pandemic.
World Neurosurg
; 139: e859-e863, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-367037
ABSTRACT
BACKGROUND:
The coronavirus 2019 (COVD-19) pandemic has drastically disrupted the delivery of neurosurgical care, especially for the already at-risk neuro-oncology population. The sudden change to clinic visits has rapidly spurned the implementation of telemedicine. A recommendation care paradigm of neuro-oncologic patients limited by telemedicine has not been reported.METHODS:
A summary of a multi-institution experience detailing the potential benefits, pitfalls, and the necessary considerations to outpatient care of neurosurgical oncology patients.RESULTS:
There are limitations and advantages to incorporating telemedicine into the outpatient care of neuro-oncology patients. Telemedicine-specific considerations for each step and stakeholder of the appointment (physician, patient, scheduling, previsit, imaging, and physical examination) are examined.CONCLUSIONS:
Telemedicine, pushed to prominence during this COVID-19 pandemic, is a powerful and possibly preferential tool for the future of outpatient neuro-oncologic care.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Telemedicine
/
Coronavirus Infections
/
Ambulatory Surgical Procedures
/
Betacoronavirus
/
Medical Oncology
/
Neurosurgery
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
World Neurosurg
Journal subject:
Neurosurgery
Year:
2020
Document Type:
Article
Affiliation country:
J.wneu.2020.05.140
Similar
MEDLINE
...
LILACS
LIS